• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • DeviceTalks Weekly
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

EDAP TMS SA

FDA clears Edap’s Focal One prostate treatment

June 8, 2018 By Fink Densford

Edap (NSDQ:EDAP) said yesterday it won FDA 510(k) clearance for its Focal One device designed for prostate tissue ablation procedures. The French company’s Focal One device uses both magnetic resonance and 3D biopsy data, alongside real-time ultrasound imaging, to allow urologists to view 3D images of the prostate while using high intensity ultrasound to ablate the […]

Filed Under: 510(k), Food & Drug Administration (FDA), Regulatory/Compliance, Ultrasound Tagged With: EDAP TMS SA

Edap submits new FDA 510(k) for Focal One HIFU

September 12, 2017 By Fink Densford

Edap (NSDQ:EDAP) said today it submitted a new FDA 510(k) application for its next-gen high-intensity focused ultrasound Focal One device designed to treat prostate cancer after withdrawing its previous application in July. The new application alllowed the France-based company to include a new set of clinical data, which it had decided to include following “advanced discussions” with […]

Filed Under: 510(k), Food & Drug Administration (FDA), Regulatory/Compliance, Ultrasound Tagged With: EDAP TMS SA

EDAP submits FDA 510(k) for Ablatherm Fusion HIFU device

August 1, 2017 By Fink Densford

Edap (NSDQ:EDAP) said this week it submitted an FDA 510(k) application for its next-gen Ablaterm Fusion device. The Lyon, France-based company’s next-generation Ablatherm Fusion is a robotic high-intensity focused ultrasound device designed to allow urologists to import pre-treatment diagnostic info, including MRI images and 3D biopsy maps, and merge them with live ultrasound images during prostate […]

Filed Under: 510(k), Food & Drug Administration (FDA), Imaging, Oncology, Regulatory/Compliance Tagged With: EDAP TMS SA

EDAP pulls FDA bid for Focal One, plans to resubmit with new data

July 18, 2017 By Fink Densford

Edap (NSDQ:EDAP) said today it withdrew the FDA 510(k) application for its next-gen high-intensity focused ultrasound Focal One device designed to treat prostate cancer. The French company said that following “advanced discussions” with the federal watchdog, it plans to submit a new 510(k) application which includes new clinical data. “As mentioned during our last quarterly call, a […]

Filed Under: 510(k), Food & Drug Administration (FDA), Oncology, Regulatory/Compliance, Ultrasound Tagged With: EDAP TMS SA

EDAP touts CMS reimbursement win for HIFU prostate ablation

May 22, 2017 By Fink Densford

Edap (NSDQ:EDAP) today touted that the Centers for Medicare & Medicaid Services established reimbursement billing codes for high intensity focused ultrasound ablation procedures for prostate tissue. The French company said that the new CMS C-code covering HIFU ablation of prostate tissue procedures will take effect July 1. The code will cover procedures performed by its HIFU […]

Filed Under: Business/Financial News, Ultrasound Tagged With: EDAP TMS SA

Edap looks to raise $11m in direct placement round

April 7, 2016 By Fink Densford

Edap (NSDQ:EDAP) said today it inked an agreement with institutional investors for the placement of 3.3 million shares at $3.50 a piece, bringing in an estimated $11.5 million for the company. Investors in the round will receive warrants to purchase up to 3.3 million shares at an exercise price of $4.50 per share, exchangeable beginning 6 […]

Filed Under: Business/Financial News, Oncology Tagged With: EDAP TMS SA

Edap seeks FDA nod for Focal One HIFU

April 6, 2016 By Fink Densford

Edap (NSDQ:EDAP) said today it submitted an application for FDA 510(k) clearance for its next-gen high-intensity focused ultrasound Focal One device designed to treat prostate cancer. The company said the new submission comes following the FDA 510(k) clearance of its Ablatherm Robotic HIFU designed for the ablation of prostate tissue, which it won last November. “We […]

Filed Under: 510(k), Food & Drug Administration (FDA), Oncology, Regulatory/Compliance Tagged With: EDAP TMS SA

Edap slips shareholders lawsuit

November 12, 2015 By Brad Perriello

Edap (NSDQ:EDAP) said yesterday that the appeal deadline lapsed for a shareholders lawsuit filed after an FDA advisory panel recommended against approval for its its Ablatherm device for treating prostate cancer. EDAP shares plunged last year after the FDA’s Gastroenterology & Urology Devices panel voted that the device did not appear to be effective or safe. Ablatherm, which won […]

Filed Under: Legal News, Radiosurgery/Radiation therapy, Urology Tagged With: EDAP TMS SA

FDA clears Edap’s Ablatherm prostate device

November 9, 2015 By Brad Perriello

Edap (NSDQ:EDAP) said today that it won 510(k) clearance from the FDA for its Ablatherm, less than a month after a similar device from rival SonaCare won a nod from the federal safety watchdog. The Ablatherm device, like SonaCare’s Sonablate 450, is designed to ablate prostate tissue using high-intensity focused ultrasound. After a years-long dance with the FDA that […]

Filed Under: Food & Drug Administration (FDA), Radiosurgery/Radiation therapy, Regulatory/Compliance, Urology Tagged With: EDAP TMS SA, SonaCare Medical

FDA clears SonaCare HIFU prostate device, prompts Edap to yank de novo, go for 510k

October 15, 2015 By Fink Densford

SonaCare said it won FDA pre market approval for its high intensity focused ultrasound device designed to treat prostate cancer, causing competitor EDAP (NSDQ:EDAP) to yank the de novo application for its Ablatherm HIFU. SonaCare said its Sonablate 450 will be available in the U.S. this October. “The FDA regulatory authorization to market Sonablate in the […]

Filed Under: Food & Drug Administration (FDA), Oncology, Pre-Market Approval (PMA), Regulatory/Compliance Tagged With: EDAP TMS SA, SonaCare Medical

Edap revives Ablatherm HIFU FDA approval bid

August 25, 2015 By Fink Densford

EDAP (NSDQ:EDAP) said today it hopes to renew the de novo application for its Ablatherm HIFU prostate cancer device after responding to a “deficiency list” letter it received in July. The letter detailed a 4-item list of issues and put the de novo process for Ablatherm, a computer-controlled high-intensity focused ultrasound device designed to ablate the entire prostate gland, […]

Filed Under: Clinical Trials, Food & Drug Administration (FDA), Regulatory/Compliance, Ultrasound Tagged With: EDAP TMS SA

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS